Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Kyung-Ah | - |
dc.contributor.author | Hwang, Insik | - |
dc.contributor.author | Park, Hang-Soo | - |
dc.contributor.author | Oh, Seung-Ick | - |
dc.contributor.author | Kang, Seongman | - |
dc.contributor.author | Hong, Sunghoi | - |
dc.date.accessioned | 2021-09-05T07:25:18Z | - |
dc.date.available | 2021-09-05T07:25:18Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-07 | - |
dc.identifier.issn | 1860-6768 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/98111 | - |
dc.description.abstract | Huntington's disease (HD) is a fatal inherited neurodegenerative disorder characterized by progressive loss of neurons in the striatum, a sub-cortical region of the forebrain. The sub-cortical region of the forebrain is associated with the control of movement and behavior, thus HD initially presents with coordination difficulty and cognitive decline. Recent reprogramming technologies, including induced pluripotent stem cells (iPSCs) and induced neural stem cells (iNSCs), have created opportunities to understand the pathological cascades that underlie HD and to develop new treatments for this currently incurable neurological disease. The ultimate objectives of stem cell-based therapies for HD are to replace lost neurons and to prevent neuronal dysfunction and death. In this review, we examine the current understanding of the molecular and pathological mechanisms involved in HD. We discuss disease modeling with HD-iPSCs derived from the somatic cells of patients, which could provide an invaluable platform for understanding HD pathogenesis. We speculate about the benefits and drawbacks of using iNSCs as an alternative stem cell source for HD treatment. Finally, we discuss cell culture and engineering systems that promote the directed differentiation of pluripotent stem cell-derived NSCs into a striatal DARPP32(+) GABAergic MSN phenotype for HD. In conclusion, this review summarizes the potentials of cell reprogramming and engineering technologies relevant to the development of cell-based therapies for HD. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.subject | HUMAN NEURODEGENERATIVE DISORDERS | - |
dc.subject | STRIATAL PROJECTION NEURONS | - |
dc.subject | ADULT HUMAN FIBROBLASTS | - |
dc.subject | WILD-TYPE HUNTINGTIN | - |
dc.subject | MUTANT HUNTINGTIN | - |
dc.subject | DIRECT CONVERSION | - |
dc.subject | FUNCTIONAL-NEURONS | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | MOUSE MODEL | - |
dc.subject | IN-VITRO | - |
dc.title | Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, Seung-Ick | - |
dc.contributor.affiliatedAuthor | Kang, Seongman | - |
dc.contributor.affiliatedAuthor | Hong, Sunghoi | - |
dc.identifier.doi | 10.1002/biot.201300560 | - |
dc.identifier.scopusid | 2-s2.0-84903815565 | - |
dc.identifier.wosid | 000339157300003 | - |
dc.identifier.bibliographicCitation | BIOTECHNOLOGY JOURNAL, v.9, no.7, pp.882 - 894 | - |
dc.relation.isPartOf | BIOTECHNOLOGY JOURNAL | - |
dc.citation.title | BIOTECHNOLOGY JOURNAL | - |
dc.citation.volume | 9 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 882 | - |
dc.citation.endPage | 894 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.subject.keywordPlus | HUMAN NEURODEGENERATIVE DISORDERS | - |
dc.subject.keywordPlus | STRIATAL PROJECTION NEURONS | - |
dc.subject.keywordPlus | ADULT HUMAN FIBROBLASTS | - |
dc.subject.keywordPlus | WILD-TYPE HUNTINGTIN | - |
dc.subject.keywordPlus | MUTANT HUNTINGTIN | - |
dc.subject.keywordPlus | DIRECT CONVERSION | - |
dc.subject.keywordPlus | FUNCTIONAL-NEURONS | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | MOUSE MODEL | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordAuthor | Cell therapy | - |
dc.subject.keywordAuthor | Human cell model | - |
dc.subject.keywordAuthor | Huntington&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | Medium spiny neuron | - |
dc.subject.keywordAuthor | Reprogramming technology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.